Carregant...
Immune-related alopecia (areata and universalis-type) in cancer patients receiving immune checkpoint inhibitors
CTLA-4, PD-1, and PD-L1 monoclonal antibodies, commonly known as immune checkpoint inhibitors, are used for the treatment of various malignancies. The mechanism of action involves the inhibition of negative regulators of immune activation, which results in many patients developing immune-related adv...
Guardat en:
| Publicat a: | Br J Dermatol |
|---|---|
| Autors principals: | , , , , , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
2017
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5459625/ https://ncbi.nlm.nih.gov/pubmed/27943234 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/bjd.15237 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|